PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7979186-8	1994	These results suggested that the mechanism responsible for the augmentation of tumor cell susceptibility by ubenimex may be a result of the alteration of their sensitivity to some Iytic factors released by LAK cells.	ubenimex	108-116	alpha kinase 1	Homo sapiens	206-209	
7979186-2	1994	The susceptibility of both MKN-45 cells and KATO-III cells to LAK cells was enhanced by treatment with ubenimex for 48 h (p < 0.05), and the optimal concentration for this effect was 10 micrograms/ml.	ubenimex	103-111	alpha kinase 1	Homo sapiens	62-65	
7979186-3	1994	The susceptibility of ubenimex treated KATO-III cells to CD3+ LAK cells, especially to those also expressing CD8, was enhanced.	ubenimex	22-30	alpha kinase 1	Homo sapiens	62-65	
7979186-7	1994	Lysis or the inhibition of DNA synthesis of tumor cells by LAK cell supernatant was enhanced by ubenimex.	ubenimex	96-104	alpha kinase 1	Homo sapiens	59-62